Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

This study is exploring if a scheduled meditation program can help patients who are having a pancreatectomy (surgery to remove part or all of the pancreas) feel better after their operation. Many patients experience pain, anxiety, and fatigue after this surgery. This study uses the Headspace app for mindfulness meditation and asks participants to wear an activity tracker. We want to see if this approach is practical and if it can reduce anxiety. We're also looking at how it might affect pain and sleep quality. You might be able to join if you are 18 or older, have a smartphone you're comfortable using, and are scheduled for a pancreatectomy. The study aims to enroll 70 participants.

Study design
This interventional study plans to enroll 70 participants and will compare two groups: one receiving early access to Headspace meditation and another receiving it later.
What's involved
You would install required apps on your smartphone, wear a Garmin activity tracker throughout the study, and complete mindfulness meditation sessions daily for several weeks before and after surgery. You will also complete surveys.
Compensation
Not stated in the trial record.
Follow-up
You would be followed for up to 6 months to assess retention and compliance, and anxiety symptoms are measured up to day 28.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07608458

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
City of Hope Medical Center
~70 participants
Updated 2026-08-20 on ClinicalTrials.gov
What's tested:ActigraphyOnline Mindfulness MeditationSmartphone Application-based InterventionSurvey Administration

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of enrolled patients who complete the final study assessment (retention)
Measured over Up to 6 months
+3 more outcomes measured
Hepatocellular Carcinoma
Pancreas Cancer
Biliary Tract Neoplasms

NCT07608458

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • City of Hope Medical Center

    Duarte, Californiastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Bradford Kim · PRINCIPAL_INVESTIGATOR · City of Hope Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Documented informed consent of the participant and/or legally authorized representative
Willing to install required apps on personal smartphone
Willing to wear a Garmin wearable device throughout the study
Age: ≥ 18 years
Ability to read and understand English for questionnaires
Owns a smartphone
Comfortable with routine smartphone use
Scheduled to undergo pancreatectomy

Exclusion

Participants with prior formal training in meditation or mindfulness (e.g., completion of structured courses, workshops, or certification programs)
Participants who currently engage in a structured meditation or mindfulness practice, including regular use of mobile applications (e.g., Headspace, Calm, or similar platforms) or other formalized routines
  • Proportion of enrolled patients who complete the final study assessment (retention)Up to 6 months

    Retention will be considered feasible if ≥ 70% of enrolled participants are retained. Will be estimated along with the 95% exact binomial confidence interval.

  • Proportion of prescribed meditation modules completed (compliance)Up to 6 months

    Each participant's proportion of completed meditation modules will be calculated using usage data from the Headspace mobile application. Participants will then be classified as high (\> 60%), medium (20-60%), or low (\< 20%) compliance. Will be estimated along with the 95% exact binomial confidence interval.

  • Change in patient-reported anxiety symptomsFrom baseline up to day 28

    Measured using the State-Trait Anxiety Inventory (STAI). Response is defined as a reduction of at least 6 points on STAI at date of surgery date relative to baseline. The proportion of participants meeting this threshold will be reported. Will be estimated along with the 95% exact binomial confidence interval. Within-group mean change in STAI will be examined using paired t-tests (comparing any two time points of interest).

  • Proportion of invited patients who agree to participate (recruitment)Up to 6 months

    Recruitment will be considered feasible if ≥ 50% of eligible patients enroll. Will be estimated along with the 95% exact binomial confidence interval.